Navigation Links
MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
Date:9/18/2007

NEW JERSEY, Sept. 18 /PRNewswire-FirstCall/ - MaxLife Fund Corp. (OTC: MXFD), is pleased to announce that they have appointed Daniel E. Kahan to its' Advisory Board.

Mr. Kahan has an extensive international actuarial background in the life insurance industry. He has hands-on experience and knowledge of the life settlements market in North America. After earning a B.Sc. (Honors) in Mathematics from University College, London, England, he qualified as an Associate of the Institute of Actuaries in 1984. He worked for 3 years in South Africa for Metropolitan Life, before moving to North America. In Toronto, Ontario, Canada he worked for Sun Life and Zurich Life. He also worked for Blue Cross in Chicago, Illinois, U.S.A.

In 1994 he founded Canadian Life Line in Nova Scotia, to provide insurance secured loans, with the approval of the Nova Scotia Superintendent of Loans & Insurance. In July 2001 he was a panel member at the Society of Actuaries Product Development Meeting session in Toronto on Life Settlements.

"Life Settlements is one of the fastest growing sectors and I am looking forward to assist MaxLife Fund Corp. to become one of the leading companies in this industry," stated Mr. Kahan.

Bennett Kurtz, Chairman and CEO, "As we are in the process of building a strong team to lead MaxLife Fund Corp., we welcome Mr. Kahan, and value his experience and expertise in the Life Settlement industry."

MaxLife Fund Corp. is a fund designated to excel in the Life Settlement sector and to partner with revenue generating businesses that are profitable, in the health sector. MaxLife is committed to create value for its shareholders by becoming one of the leading funds in the life and health sector.

Cautionary Statement Pursuant to Safe Harbor Provisions of the Private

Securities Litigation Reform Act of 1995:

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties. The actual results that the Company achieves may differ materially from any forward-looking statements due to such risks and uncertainties. The Company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this news release.


'/>"/>
SOURCE MaxLife Fund Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. WHO lifts HongKong advisory
3. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
4. Doctors Said – ‘Stop Pressurising NHS Advisory Bod’
5. Mercks Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
6. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
7. FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
8. LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
9. Study casts doubt on keyboard ills
10. Who Board To Discuss Asian Tsunami Related Health Issues
11. Abdominal Crunches Not The Best Option For Wash Board Abs.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: